RGX-111 GENE THERAPY FOR THE TREATMENT OF SEVERE MUCOPOLYSACCHARIDOSIS TYPE I (MPS I): INTERIM ANALYSIS OF DATA FROM A PHASE 1/2 STUDY

被引：0
|
作者：
Wang, Raymond [1 ]
Ficicioglu, Can [2 ]
Giugliani, Roberto [3 ]
Nevoret, Marie-Laure [4 ]
Fiscella, Michele [4 ]
Yang, Lin [4 ]
Cho, Yoonjin [4 ]
Phillips, Dawn [4 ]
Falabella, Paulo [4 ]
机构：
[1] Univ Calif Irvine, CHOC Childrens Hosp, Dept Pediat, Div Metab Disorders, Orange, CA 92668 USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[3] Univ Fed Rio Grande do Sul, HCPA, Med Genet Serv, Dept Genet, Porto Alegre, RS, Brazil
[4] REGENXBIO, Rockville, MD USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
92
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [1] RGX-111 gene therapy for the treatment of severe mucopolysaccharidosis type I (MPS I): Interim analysis of data from the first in human study
    Wang, Raymond Y.
    Ficicioglu, Can H.
    Giugliani, Roberto
    Burke, Jenna
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 134 - 134
  • [2] RGX-111 Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type I (MPS I): Interim Analysis of Data from the First in Human Study
    Pisani, Laura
    Wang, Raymond
    Ficicioglu, Can
    Giugliani, Roberto
    Burke, Jenna
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR THERAPY, 2023, 31 (04) : 453 - 453
  • [3] RGX-111 GENE THERAPY FOR THE TREATMENT OF SEVERE MUCOPOLYSACCHARIDOSIS TYPE I (MPS I): INTERIM ANALYSIS OF DATA FROM THE FIRST IN HUMAN STUDY
    Gilmor, Michelle
    Wang, Raymond
    Ficicioglu, Can
    Giugliani, Roberto
    Burke, Jenna
    Fiscella, Michele
    Yang, Lin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (03) : 50 - 50
  • [4] RGX-111 gene therapy for the treatment of severe mucopolysaccharidosis type I (MPS I): Interim analysis of data from the first in-human study
    Wang, Raymond
    Ficiciolu, Can
    Giugliani, Roberto
    Nevoret, Marie-Laure
    Fiscella, Michele
    Yang, Lin
    Cho, Yoonjin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S126 - S126
  • [5] RGX-111: An Investigational Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type I (MPS I): Interim Analysis from the First-in-Human Study
    Pisani, L.
    Wang, R.
    Ficicioglu, C.
    Giugliani, R.
    Burke, J.
    Yang, L.
    Wang, H.
    Gilmor, M.
    Cho, Y.
    Mulatya, C.
    Phillips, D.
    Falabella, P.
    ANNALS OF NEUROLOGY, 2023, 94 : S68 - S68
  • [6] RGX-121 gene therapy for the treatment of severe mucopolysaccharidosis type II (MPS II): Interim analysis of data from a Phase 1/2 study
    Harmatz, P.
    Giugliani, R.
    Escolar, M.
    Ficicioglu, C.
    Fiscella, M.
    Yang, L.
    Cho, Y.
    Falabella, P.
    ANNALS OF NEUROLOGY, 2022, 92 : S170 - S170
  • [7] RGX-121 Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study
    GHiugliani, Roberto
    Escolar, Maria
    Ficicioglu, Can
    Harmatz, Paul
    Fiscella, Michele
    Yang, Lin
    Cho, Yoonjin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR THERAPY, 2022, 30 (04) : 27 - 27
  • [8] RGX-121 Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study
    Ficicioglu, C.
    Escolar, M.
    Giugliani, R.
    Harmatz, P.
    Nevoret, M-L
    Fiscella, M.
    Yang, L.
    Cho, Y.
    Phillips, D.
    Falabella, P.
    ANNALS OF NEUROLOGY, 2021, 90 : S96 - S96
  • [9] RGX-121 Gene Therapy for the Treatment of Neuronopathic Mucopolysaccharidosis Type II (MPS II): Interim Analysis of Data from the First in Human Study
    Harmatz, Paul
    Ficicioglu, Can
    Giugliani, Roberto
    Rajan, Deepa
    Hagood, Joseph
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Phillips, Dawn
    Pisani, Laura
    Falabella, Paulo
    MOLECULAR THERAPY, 2023, 31 (04) : 398 - 398
  • [10] RGX-121 gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II): Interim analysis of data from the first in human study
    Harmatz, Paul
    Ficicioglu, Can H.
    Giugliani, Roberto
    Rajan, Deepa
    Hagood, Joseph
    Fiscella, Michele
    Yang, Lin
    Gilmor, Michelle
    Cho, Yoonjin
    Phillips, Dawn
    Falabella, Paulo
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 57 - 57
12345